We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
OGT’s Genefficiency™ Genomic Services and CytoSure™ Cytogenetics Research Products Showcased at ASHG
Product News

OGT’s Genefficiency™ Genomic Services and CytoSure™ Cytogenetics Research Products Showcased at ASHG

OGT’s Genefficiency™ Genomic Services and CytoSure™ Cytogenetics Research Products Showcased at ASHG
Product News

OGT’s Genefficiency™ Genomic Services and CytoSure™ Cytogenetics Research Products Showcased at ASHG


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "OGT’s Genefficiency™ Genomic Services and CytoSure™ Cytogenetics Research Products Showcased at ASHG"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Visitors to the 59th annual meeting of the American Society of Human Genetics in Honolulu, Hawaii, will have ample opportunity to see the latest solutions from Oxford Gene Technology (OGT) – ranging from disease research services to cytogenetics research products.

As well as having a strong presence in the exhibitors’ hall, OGT will be showcasing its comprehensive solutions for disease and cytogenetics research at a satellite meeting held in room 325 of the Convention Center at 12 noon on Thursday October 22nd, entitled ‘From disease to cytogenetics research – an integrated CNV analysis platform from Oxford Gene Technology’.

In the meeting, Dr Jonathan Sebat, Associate Professor of Human Genetics at Cold Spring Harbor Laboratory, will review some of the challenges in cohort studies, while Dr David Ledbetter, Professor of Human Genetics at Emory University School of Medicine, will elaborate on some of the considerations in taking aCGH to the clinic, including the ISCA Consortium and Public Database.

Dr John Anson, R&D Director at OGT, commented: “We are delighted to welcome two distinguished guest speakers to the podium, who will be discussing developments from disease to cytogenetics research. We will outline how OGT has aligned its portfolio of products and services to support these efforts.”

OGT’s Genefficiency™ genomic services and CytoSure™ cytogenetic aCGH products offer an integrated and standardized solution for array-based disease association studies and cytogenetics research.
Advertisement